Market Alert : Crude Turns Volatile Amid Delay in U.S. Military Action on Iran; Bond Markets Near Multi-Year Highs

2 ASX Momentum Stocks to Watch Now: GYG and IperionX


Source: Kapitales Research
Highlights:

  • GYG abandons Chicago operations, but investors see stronger long-term capital discipline.
  • Australia expansion targets reignite optimism despite looming US$40 million exit impact.
  • IperionX boosts titanium manufacturing capacity as US industrial demand accelerates.

Market Moves Intensify
Australian investors responded positively to two sharply different corporate developments on Friday, with both companies highlighting a stronger focus on operational execution and long-term strategic positioning.

  • Guzman y Gomez Limited (ASX: GYG) traded at approximately AU$21.00, rising over 16% after announcing its withdrawal from the US market.
  • IperionX Limited (ASX: IPX) also drew investor attention following a major expansion of its US titanium manufacturing platform, with the stock trading at approximately AU$5.13, up over 4.50%.

Fast-Food Chain Exits US
Guzman y Gomez confirmed it will immediately cease operations at its Chicago restaurants after the business failed to meet financial performance targets. The Mexican fast-food chain stated the US expansion would require significantly more time and capital than initially anticipated, prompting management to halt further investment in the market.
Founder and Co-CEO Steven Marks said the company remained confident in its food offering and customer experience, but sales momentum in the US had not improved sufficiently. GYG expects the exit to result in a one-off profit and loss impact of between US$30 million and US$40 million in FY26, although the cash component is expected to remain below US$15 million. The company also confirmed the decision would not affect its FY26 final dividend.
Despite the shutdown, investors welcomed management’s renewed focus on Australia, where GYG continues to report strong unit economics and expansion opportunities. The company reaffirmed plans to open 32 new restaurants this financial year and forecast Australia segment underlying EBITDA of about AU$85 million for FY26, representing 29% growth from the previous year.
Management also maintained confidence in international growth through franchise markets such as Singapore and Japan, both of which continue to deliver healthy sales growth and new store openings.
Titanium Producer Expands Capacity
IperionX revealed that it has activated a newly installed 300-ton six-axis SACMI powder metallurgy press at its Virginia Titanium Manufacturing Campus, marking a major step forward in the company’s domestic titanium production capabilities. The advanced equipment is expected to enhance manufacturing efficiency and broaden the range of titanium components the company can produce for US industrial, aerospace and defense sectors. The new system triples existing powder metallurgy capacity and enables the production of more complex titanium parts for aerospace, defense and industrial customers.
The newly commissioned system can complete as many as 24 pressing operations each minute, giving it the potential to manufacture roughly 11 million single-cavity components annually under standard production. According to the company, the technology improves precision, repeatability and production flexibility while reducing manufacturing waste and supply-chain dependence.
IperionX said the facility uses titanium powder sourced through its patented HAMR™ process and integrates with its HSPT™ sintering and forging technologies. The company expects additional furnace infrastructure to be delivered in June through the US Government-backed IBAS expansion initiative, strengthening its ability to support customer approvals and scale production volumes.
Growth Strategies Diverge
The contrasting announcements underscore how investors are increasingly rewarding strategic discipline and operational clarity. For GYG, exiting the US market appears to have reassured shareholders concerned about capital allocation risks, while the company’s Australian growth profile remains intact.
For IperionX, the manufacturing expansion strengthens its position within critical US supply chains at a time when domestic sourcing of advanced industrial materials is becoming a strategic priority. Both companies now enter their next growth phase with a sharper focus on scalability, efficiency and long-term shareholder value.
Note- All data presented is based on information available at the time of writing.Disclaimer for Kapitales ResearchThe materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au